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We have identiﬁed a novel mAb, SG31, which recognizes the mouse integrin a4 subunit. Unlike the
epitopes recognized by other anti-a4 antibodies, the SG31 epitope is expressed on subpopulations of
thymocytes and peripheral T cells. After manganese ion, but not phorbol myristic acetate activation, the
epitope is induced and expressed on the majority of peripheral T cells. These data suggest that the SG31
epitope is an activation epitope and that manganese ions activate a4 integrins by inducing a
conformational change. Comparative ﬂow cytometric analyses showed that the SG31 epitope as well as
the epitope detected by other anti-a4 antibodies is expressed on all B lineage cells. In the T lineage,
expression of the a4 integrins is down-regulated during thymocyte development. Although mature
thymocytes still express the a4 integrins, they lose almost entirely the activation epitope recognized by
SG31. In contrast, the most immature thymocytes express high levels of this epitope. In the periphery,
SG31 epitope is expressed mostly by activated T cells, in contrast to the overall population of T cells
that express the a4 integrins at homogenous levels. These results suggest that the activation of the a4
integrins is parallel to that of T cells.
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INTRODUCTION
The a4 integrin a4b7 and a4b1 are heterodimeric cell
surface adhesion molecules involved in leukocyte
cell–cell and cell–matrix interactions and migration
(Elices, 1994). a4b1 is distributed on essentially all
hemopoietic lineage precursors and most mature blood
cells except erythrocytes, platelets and neutrophils
(Elices, 1994; Lobb and Hemler, 1994). a4b1 expression
can be induced on activated neutrophils (Reinhardt et al.,
1996) and upregulated during T and B cell activation
(Hemler, 1990; Postigo et al., 1991). It is also expressed
on non-lymphoid tissues in developing embryos (Stepp
et al., 1994; Sheppard et al., 1994) and various non-
hematopoietic tumor cells (Lobb and Hemler, 1994). The
ligands for a4b1 are the alternatively spliced connecting
segment-1 (CS1) region of extracellular matrix protein
ﬁbronectin and domains 1 and 4 of vascular cell adhesion
molecule-1 (VCAM-1, CD106) (Elices, 1994). After its
activation, a4b1 can also interact with other sequences on
ﬁbronectin, thrombospondin and the bacterial coat protein
invasin (Lobb and Hemler, 1994). a4b7 is expressed on
most lymph node T and B cells, on the gut homing subset
of CD4
þ memory T cells, and on lymphocytes present
in rheumatoid synovium (Lobb and Hemler, 1994).
In human, natural killer (NK) cells, eosinophils, and
newborn blood B and T cells show relatively homo-
geneous expression of a4b7, while adult blood B and
T cells show more heterogeneous expression (Erle et al.,
1994). The known ligands for a4b7 include the
ﬁbronectin CS-1 region, VCAM-1, and the mucosal
addressin cell adhesion molecule-1 (MAdCAM-1)
(Lobb and Hemler, 1994). In addition, the a4 subunit
itself may function as a ligand for a4b1 and a4b7
(Altevogt et al., 1995).
The a4 integrins play important roles in embryogenesis
(Stepp et al., 1994) including lympho-hemopoiesis
(Miyake et al., 1991; Hamamura et al., 1996), lymphocyte
trafﬁcking/homing (Strauch et al., 1995; Abitorabi et al.,
1996), leukocyte extravasation during inﬂammation
(van Dinther-Janssen et al., 1991; Engelhardt et al.,
1995), lymphocyte activation during immune responses
(Ferguson and Kupper, 1993), differentiation and genera-
tion of memory cells within the microenvironment of
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Koopman et al., 1991). The a4 deﬁcient mice have
defects in placental and cardiac development leading to
fetal death (Yang et al., 1995). In mice chimeric for a4
expression, T and B cell development is severely impaired
in adults. In addition, T cell homing to Peyer’s patches is
blocked (Arroyo et al., 1996). However, monocytes and
NK cells can develop normally. a4b7 is involved in
lymphocyte homing to intestinal mucosa (Cepek et al.,
1993; Strauch et al., 1995). The other member of the b7
integrin subfamily, aEb7, is expressed on intraepithelial
lymphocytes (Kilshaw and Murant, 1990) and interacts
with E-cadherin on intestinal epithelium (Cepek et al.,
1994). a4 Integrins are also involved in pathogenesis of
metastatic melanoma, atherosclerotic plaques, and rheu-
matoid arthritis and disease progression in many animal
models such as experimental autoimmune encephalomye-
litis, autoimmune diabetes, antigen-induced asthma, and
so on (Elices, 1994; Lobb and Hemler, 1994).
Use of monoclonal antibodies has contributed greatly to
our current knowledge of a4 integrin structure and their
functions. Here we describe the identiﬁcation of a new
anti-murine a4 mAb SG31. Comparative studies with
SG31 and several other anti-mouse a4 mAbs revealed that
SG31 recognizes an epitope which is not present on all a4
integrin molecules. This epitope can be up-regulated on
peripheral T cells by manganese ions which reportedly
activate a4 integrins by inducing conformational changes.
Our data strongly suggest that SG31 recognizes an
activation epitope and that a4 integrins exist in different
activation statuses on B and T lymphocytes. SG31 may
therefore provide an important tool to elucidate the
mechanisms of a4 integrin-mediated physiological and
pathological processes.
RESULTS
SG31 Recognizes the Integrin A4 Subunit
Preliminary immunoﬂuorescence staining and ﬂow cyto-
metric analyses showed that mAb SG31 (rat g2a, k) reacts
with blood cells of multiple lineages and it precipitated
two subunits (160 and 100kDa, respectively) from pro-B
lymphoma cell line 38B9. Since integrins are the only
known leukocyte antigens consisting of heterodimers with
similar molecular weight, our initial data suggest that
SG31 may react with a4b1o raLb2 because of their
comparable distribution on leukocytes. When mouse bone
marrow cells were co-stained with SG31 and anti-a4o r
anti-aL antibodies, SG31 showed a staining proﬁle similar
to that of anti-a4, but not that of anti-aL (data not shown).
Since the integrin a4 subunit can associate with either
b1o rb7 to form a4b1 and a4b7, we next attempted to
determine the nature of the integrin subunit recognized
by SG31. The cell lines 38B9 and TK-1, which express
a4b1 and a4b7, respectively, were stained with SG31 and
antibodies to a4 (PS/2), b1 (KMI6) and b7 (M293).
We found that SG31 reacted with both cell lines
irrespective of the associated b subunit (Fig. 1a). The
data strongly suggested that SG31 recognizes a4 itself.
We reported previously that the a4 subunits on TK1
cells undergo post-translational cleavage giving rise to the
a4
80 and a4
70 molecules, and that the association of a4
and b7 is dependent on the presence of cations (Ruegg
et al., 1992). To conﬁrm that SG31 recognizes the a4
subunit, we did immunoprecipitation studies with TK1
using SG31 and other antibodies. In the presence of
cations (Ca
2þ,M g
2þ and Mn
2þ), SG31 precipitated
proteins (lane 2) of similar size to those of a4
150, b7, a4
80
and a4
70 as precipitated by PS/2 (lane 3) and M293
(lane 4) (Fig. 1b). In the absence of cations (depleted by
EDTA and EGTA), SG31 precipitates only proteins (lane
7) of similar size to a4
150 and a4
80 as that precipitated by
PS/2 (lane 8), M293 precipitated only b7 (lane 9). The
control antibody (lanes 1 and 6) and KMI6 (anti-integrin
b1 subunit) (lanes 5 and 10) did not precipitate any
protein. That the same precipitating pattern is shared by
SG31 and PS/2 strongly suggests that SG31 recognizes a4
subunits.
We have further conﬁrmed that SG31 recognizes a4b y
immunodepletion studies with 38B9 cells which express
only a4b1 (Fig. 1c). Iodinated 38B9 cell lysates were
depleted with PS/2- or SG31-coupled Afﬁ-gel 10 beads.
The depleted lysates were then precipitated with PS/2- or
SG31-coupled beads, respectively (Fig. 1c). The unde-
pleted lysates were precipitated with control antibody-,
SG31-, or PS/2-coupled beads for comparison. SG31
precipitated proteins (lane 6) of similar size to a4 and b1
as precipitated by PS/2 (lane 7). It is noticeable that the
amount of proteins precipitated by SG31 is smaller than
that precipitated by PS/2. After PS/2 or SG31 depletion,
the amount of proteins left which can be further
precipitated by either PS/2 or SG31 is signiﬁcantly
reduced (lanes 1–4). The depletion was most dramatic
when the lysates were precleared by PS/2 (lanes 1 and 2)
and when the lysates were precleared with SG31 and then
precipitated with SG31 (lane 4). After SG31 immunode-
pletion, there was still a signiﬁcant amount of material
remaining, which can be precipitated by PS/2 (lane 3). The
control antibody did not precipitate any protein corres-
ponding to a4o rb1 (lane 5). These data demonstrated that
SG31 recognizes the murine integrin a4 subunits, more
speciﬁcally the N-terminal fragment of a4 subunit, a4
80,
as does PS/2 (Fig. 1b). It was of interest that the a4
subunits on 38B9 cells do not undergo obvious cleavage in
contrast to those on TK1 cells (Fig. 1b,c).
SG31 Recognizes an Epitope Present only on a T Cell
Population
Our previous studies have shown that SG31 staining is
less intense than that of PS/2 on some cell lines (data
not shown) and SG31 precipitated smaller amount of
a4 integrin molecules than PS/2 (Fig. 1). These
F. SHU et al. 74ﬁndings suggest that SG31 recognizes an epitope that is
not present on all a4 integrin molecules. To test this
possibility, we stained freshly harvested spleen and
mesenteric lymph node cells of young BALB/c mice
and compared the staining intensities of SG31 and PS/2
on B (IgM
þ) and T (CD3
þ) cells (Fig. 2). Our data
revealed that SG31 stained most IgM
þ cells in spleen
and mesenteric lymph node as did PS/2, though SG31
staining is more heterogeneous than that of PS/2.
Interestingly, SG31 stained only a minor subpopulation
of CD3
þ cells in both tissues while PS/2 stained almost
all T cells. In spleen, both SG31 and PS/2 stained
brightly a IgM
2CD3
2 population which is presumably
of myeloid lineage.
All B Lineage Cells Express the SG31 Epitope
In order to further characterize the expression of the SG31
epitope in different lymphocyte compartments, we
compared the staining of SG31 and PS/2 on different
lymphocyte subsets using three-color staining and ﬂow
cytometric analyses. Bone marrow is the primary
hemopoietic organ in adult mice and generates all lineages
of blood cells except T cells. We focused our studies on B
lineage cells in the bone marrow and stained bone marrow
cellsfromyoungadultBALB/cmicewithcontrolantibody,
SG31, or PS/2 (detected by PE-conjugated goat anti-rat
IgG), CY2-conjugated anti-B220, and FITC-conjugated
anti-CD43 or anti-IgM. B lineage cells in the bone marrow
can be delineated into sequential stages based on the
expression of surface markers (B220
þCD43
þ pro-B cells,
B220
þCD43
2IgM
2 pre-B cells, B220
þIgM
þ B cells)
(Hardy et al., 1991). Our studies showed that all B lineage
cells in each compartment of the bone marrow express the
a4 integrins and the SG31 epitope (Fig. 3a and b).
Splenic B cells can be divided into three subsets based
on surface expression of IgM and CD21 by ﬂow
cytometric analysis. Follicular (FO) B cells are
IgM
þCD21
þ, marginal zone (MZ) B cells IgM
high
CD21
high, and newly-formed (NF) B cells IgM
high
CD21
low (Kraal, 1992; Oliver et al., 1997). Spleen cells
from young adult BALB/c mice were stained with control
FIGURE 1 SG31 recognizes the integrin a4 subunit. (a) SG31 reacted with a4-expressing cell lines no matter what b subunit is expressed. 38B9 and
TK1 cell lines were stained with control antibody (dotted line), SG31, PS/2 (anti-a4), KMI-6 (anti-b1), and M293 (anti-b7). Stained cells were analyzed
by ﬂow cytometry. (b) Immunoprecipitation patterns of TK1 cells by SG31 and PS/2 are the same. TK1 lymphoma cells were iodinated and lysed with
1% NP-40 lysis buffer supplemented with cations or depleted of cations. Precleared lysates were incubated with a control Ab-, SG31-, PS/2-, m293-, and
KMI6-coupled beads and run under non-reducing conditions. Similar results were obtained under reducing conditions (data not shown). (c) SG31 and
PS/2 depleted the integrin a4 and b1 subunits from 38B9 cells. Precleared lysates were further depleted with 3 rounds of PS/2- or SG31-coupled Afﬁ-gel
10 beads and precipitated with PS/2- and SG31-coupled Afﬁ-gel 10 beads. Lysates without depletion were precipitated with control Ab-, SG31-, and
PS/2-coupled beads for comparison.
ACTIVATION OF MURINE a4 INTEGRINS 75antibody, SG31, or PS/2 (detected by PE-conjugated goat
anti-rat IgG), FITC-conjugated anti-IgM, and biotinylated
anti-CD21 (detected by SA-CU5). Flow cytometric
analysis showed that all three B cell subsets express the
a4 integrins and the SG31 epitope (Fig. 3c). However,
SG31 staining again seems more heterogeneous than that
of PS/2 (Fig. 3a–c).In summary, detailed analyses of the
early B cell compartments and peripheral B cell subsets
showed no major difference in expression of the SG31
epitope and total a4 integrins as detected by PS/2.
FIGURE 3 All B lineage cells express the SG31 epitope. Bone marrow cells gated from the different compartments in young adult BALB/c mice were
all stained with SG31 and PS/2.
FIGURE 2 SG31 epitope is not present on all a4 integrin molecules, especially on T cells. Spleen or mesenteric lymph node cells from young BALB/c
mice were stained with PS/2 or SG31 and anti-IgM or anti-CD3, and analyzed with ﬂow cytometry.
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2CD8
2 Thymocytes Express High Levels of the
SG31 Epitope
We have observed that SG31 reacted with fewer
thymocytes than PS/2 (see below, Fig. 6). Then we tested
the expression of the SG31 epitope at different stages of
thymocyte development. Our data showed that
CD4
2CD8
2 (DN) thymocytes express the a4 integrins
at high levels as detected by anti-integrin a4 mAb PS/2.
During maturation, their expression is down-regulated and
CD4
þ or CD8
þ (SP) thymocytes express the a4 integrins
at low levels as reported {94}. The SG31 epitope is
expressed at the same high levels as the PS/2 epitope on
DN thymocytes, however, its expression is down-
regulated to a larger extent on more mature CD4
þCD8
þ
(DP) and SP thymocytes (Fig. 4a). A subset of
CD4
2CD8
þ thymocytes express the a4 integrins and the
SG31 epitope at high levels. These cells are most likely at
the transitional stage from DN to DP, since a4 integrins
are expressed at low levels by only a minor subpopulation
of CD3
þ thymocytes and the SG31 epitope is not
expressed by CD3
þ thymocytes at all (Fig. 4b).
Activated T Cells Express Higher Levels of a4
Integrins and Express the SG31 Epitope
To determine if only activated T cells express the SG31
epitope, we stained splenic and mesenteric lymph node
cells with SG31 together with antibodies against other
differentiation/activation antigens. Activated T cells
express CD69 and high levels of CD44. We found that
only CD69
þ and CD44
high T cells express the SG31
epitope. While almost all peripheral T cells express a4
integrins, CD69
þ and CD44
high T cells express higher
levels of these integrins as detected by PS/2 (Fig. 5a).
Activated T cells also up-regulate surface expression of
CD11a, CD25, CD38, and CD54 (Brines, 1997). They
may down-regulate surface expression of CD62L. The
expression of these activation markers together with CD95
was compared between SG31
þ (solid line) and SG31
2
(broken line) mesenteric lymph node T cells (Fig. 5b).
Flow cytometric analyses showed that SG31
þ T cells
express higher levels of CD11a and CD54. SG31
þ T cells
are also enriched for CD62L
2, CD25
þ, and especially
CD38
þ cells. Neither SG31
þ nor SG31
2 T cells express
signiﬁcant amount of CD95. Taking all these results
together, SG31
þ T cells appear to express a constellation
of markers typical of activated T cells.
Cells that Express High Levels of a4 Integrins also
Express High Levels of the SG31 Epitope
Since the activity of integrins can be modulated at several
levels including cell surface expression and afﬁnity
maturation (Garratt and Humphries, 1995), we next
compared the expression of a4 integrins and the SG31
epitope in peritoneal cavity, bone marrow, peripheral
blood, splenic, mesenteric lymph node, Peyer’s patch cells
and thymocytes from young adult BALB/c mice by
staining the cells with SG31 and the FITC-conjugated
anti-a4 mAb, 9C10. 9C10 is a commercially available Ab
which recognizes a4 integrins. We have previously shown
that SG31 and 9C10 do not block each other in terms of
binding to TK1 cells and 9C10, PS/2 and R1-2 show
similar staining patterns on fetal and adult lymphoid
tissues which differ from that of SG31 (data not shown).
FIGURE 4 CD4
2CD8
2 thymocytes express high levels of the SG31 epitope. (a) Subpopulations of thymocytes from young adult BALB/c mice
expressing SG31 (thick solid line), and PS/2 (broken line). Expression of the SG31 and PS/2 epitopes was compared on thymocyte subpopulations based
on CD4, CD8 expression. (b) Thymocytes were stained with FITC-conjugated anti-CD3, and control antibody, SG31, or PS/2, detected by
PE-conjugated goat anti-rat IgG.
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or R1-2 is that these Abs blocked the binding of each
other. Flow cytometric analysis showed that both SG31
and 9C10 reacted with all lymphocytes in peritoneal
cavity (Fig. 6). 9C10 stained most cells in the lymphocyte
gate in all other tissues. SG31 stained the cells which were
stained brightly by 9C10, however, it did not react with a
signiﬁcant number of cells which were stained modestly
by 9C10 in most lymphoid tissues, especially thymus
(consistent with Fig. 4). These results showed that the cells
expressing high levelsof the a4 integrins also express high
levels of the SG31 epitope, while the cells expressing
moderate levels of a4 integrins may not express or express
only low levels of the SG31 epitope.
SG31 Epitope is Up-regulated by Mn
21 on T Cells
It has been reported that TK1 cells use a4b7 to bind
MAdCAM-1 under ﬂow conditions. Lymph node cells
can bind efﬁciently under similar test conditions only after
their activation by PMA or Mn
2þ (Bargatze et al., 1995;
Berlin et al., 1995). SG31 and PS/2 have similar staining
intensity on TK1 cells (Fig. 1a), but they have very
different reactivity on peripheral T cells. These diffe-
rences led us to speculate that SG31 may recognize the
activated form of a4 integrins. To test this hypothesis, we
ﬁrst treated splenic and mesenteric lymph node cells with
either CaCl2, MgCl2, or MnCl2 at 2mM (the concentration
widely used in the literature), then stained with control
antibody, SG31 or PS/2 together with FITC-conjugated
anti-CD5. We found that after Mn
2þ-activation, the
expression of SG31 epitope was up-regulated on splenic
(data not shown) and lymph node T cells (Fig. 7). SG31
þ
T cells increase from 10 to 20% in spleen and from 13 to
40% in mesenteric lymph node after Mn
2þ-activation. The
staining of B cells was not affected. Mn
2þ-activation did
not change PS/2 staining on either B or T cells. Ca
2þ and
Mg
2þ at the same concentration (2mM) do not have
signiﬁcant effect on SG31 epitope induction on T cells,
consistent with their apparent failure to activate a4
integrins. PMA can also activate a4 integrins on T cells as
previously reported (Bargatze et al., 1995). We found that
PMA stimulation (for 3 days) induced expression of CD69
and CD25, up-regulated CD44 expression on subsets of
T cells, and signiﬁcantly increased the number of T cells
expressing a4 integrins but not the SG31 epitope (data not
shown). However, not all CD69
þ or CD25
þ T cells
express the SG31 epitope. Similarly, not all SG31
þ cells
express CD69 or CD25, again consistent with the ﬁndings
with fresh tissues in that SG31
þ T cells are enriched for,
but not exclusively, activated cells (Fig. 5b). Therefore,
there is no simple relationship between T cell activation
and a4 integrin activation.
SG31 Selectively Inhibits 38-b7 Cell Adhesion to
Fibronectin
38-b7 Cell line is a 38C13 pre-B lymphoma transfected
with murine b7 cDNA. Therefore, it expresses a4b7 and
can adhere to ﬁbronectin, VCAM-1 and MAdCAM-1. We
tested SG31 for its ability to inhibit 38-b7 cell adhesion to
these ligands. We found that PS/2 antibody inhibited
38-b7 cell adhesion to all these three ligands, whereas
SG31 inhibited only the adhesion of 38-b7 cells to
ﬁbronectin, but not CHO cells expressing VCAM-1 or
MAdCAM-1 (Fig. 8).
DISCUSSION
The major ﬁndings of this report are that: (i) mAb SG31
recognizes the mouse integrin a4 subunit, (ii) most T cells
express a4 integrins but not the SG31 epitope, which is in
contrast to B cells all of which express the SG31 epitope,
(iii) SG31 epitope is up-regulated on T cells by Mn
þþ,
(iv) primarily immature thymocytes and activated T cells
express SG31 epitope, (v) PMA-activated splenic T cells
FIGURE 5 Activated T cells express activated a4 integrins. (a) Only
CD69
þ and CD44
high spleen cells express the SG31 epitope. (b) Staining
ofmesentericlymphnodecells showedthatSG31
þ T cells expresshigher
levels ofCD11aand CD54.SG31
þ T cells are also enriched forCD62L
2,
CD25
þ and especially CD38
þ cells. Neither SG31
þ nor SG31
2 T cells
express CD95.
F. SHU et al. 78FIGURE 6 Cells expressing high levels of a4 integrins express them as active forms. Peritoneal cavity, bone marrow, peripheral blood, splenic,
mesenteric lymph node, Peyer’s patch cells and thymocytes from young adult BALB/c mice were stained with SG31 and 9C10 (anti-a4), and analyzed
by ﬂow cytometry.
FIGURE 7 SG31 recognizes an activation epitope that is up-regulated by Mn
2þ.
ACTIVATION OF MURINE a4 INTEGRINS 79up-regulate a4 integrins and SG31 epitope (data not
shown), and (vi) cells expressing high levels of a4
integrins also express high levels of SG31 epitope.
SG31 Recognizes Activated Murine a4 Integrins
Immunoprecipitation and immunodepletion studies
clearly demonstrated that SG31 recognizes the mouse
integrin a4 subunit, and more speciﬁcally, the a4
80
fragment. Flow cytometric and immunoprecipitation data
also revealed that mAb SG31 does not react with all a4
integrin molecules. These ﬁnding together with the
observation that the SG31 epitope is up-regulated on
T cells by Mn
2þ strongly suggests that this antibody
recognizes an activation epitope on a4 integrin molecules.
It is known that the activity of a4 integrins can be
up-regulated by Mn
2þ and PMA without an overall
increase of expression on the given cells (Garratt and
Humphries, 1995). Accumulating data suggest that Mn
2þ
and PMA activate a4 integrins by different mechanisms.
Mn
2þ, like Ca
2þ,M g
2þ, and some mAbs, may induce
conformational changes by direct interactions with the
integrin molecule (Ginsberg et al., 1992). Shimizu and
Mobley reported that cell activation with PMA treatment
can further enhance T cell adhesion to ﬁbronectin and
VCAM-1 in the presence of Mn
2þ (Shimizu and Mobley,
1993). Since PMA is a protein kinase C activator,
phosphorylation of integrin cytoplasmic domains or
integrin associated proteins may play a role in integrin
activation. Studies on other members of the integrin
family, such as aLb2 and aVb5, showed that PMA
increases adhesion by cytoskeletal-dependent processes
such as mobilization and cluster formation of integrin
molecules, and cell spreading, but not by afﬁnity
modulation (Stewart et al., 1996). Identiﬁcation of
activation epitopes on human b1 and b2 integrins has
been reported (Picker et al., 1993; Bazzoni et al., 1995). In
particular, the activation epitope of b2 integrins,
especially aLb2, recognized by mAb 24 was well studied
(Dransﬁeld et al., 1992; Picker et al., 1993). Our data
identify for the ﬁrst time an activation epitope on the
integrin a4 subunit. Unlike the mAb 24 epitope, the SG31
epitope is present on a subpopulation of peripheral T cells
in the absence of cations (when depleted by EDTA, a
chelator for all bivalent cations). This activation epitope is
signiﬁcantly induced by Mn
2þ on splenic and lymph node
T cells. Similar to the mAb 24 epitope, but to a much less
extent, Ca
2þ down-regulates and Mg
2þ (especially when
Ca
2þ ions were depleted by EGTA, a Ca
2þ-speciﬁc
chelator) up-regulates the SG31 epitope (data not shown).
We observed that short-period stimulation with PMA
(30min) does not up-regulate the SG31 epitope (data not
shown), while long-period stimulation (3 days) up-
regulate activation markers such as CD44, CD69, CD25,
and the SG31 epitope. These data conﬁrm that Mn
2þ and
PMA activate a4 integrins by different mechanisms. The
up-regulation of the SG31 epitope by Mn
2þ is dependent
on the presence of Mn
2þ during the subsequent staining
procedure, indicating that Mn
2þ induces conformational
change of a4 integrins by binding the molecules. Our
ﬁnding is consistent with the previous report that the
effects of Mn
2þ-activation wears off shortly after Mn
2þ
depletion (Bargatze et al., 1995). The effect of Mn
2þ on
SG31 epitope induction is maximal at a concentration of
2mM which is widely reported in the literature. Higher
concentration of Mn
2þ caused signiﬁcant cell damage.
Mn
2þ at 2mM is likely to be an artiﬁcial stimulus whose
physiological equivalent is still unknown.
a4 integrins can exist in a range of activation states
(Masumoto and Hemler, 1993; Lobb and Hemler, 1994).
A recent report provides evidence that cells may express
three populations of integrins: inactive (not responsive to
activating signals), transiently active or low afﬁnity
(responsive to ligand and activating signals), and stably
active and high afﬁnity (readily occupied by ligand)
(Yednock et al., 1995). Mn
2þ-activation does not induce
the SG31 epitope on all peripheral T cells (Fig. 7). One
possible explanation is that the Mn
2þ-responsive a4
integrins represent the second population mentioned
above. The up-regulation of the SG31 epitope on T cells
was not due to the binding of soluble ligands because the
contents of the buffers used in our experiments were well
deﬁned. In other experiments, buffer containing fetal calf
serum, a source of signiﬁcant amount of ﬁbronectin, was
used and no signiﬁcant difference was observed in terms
of the expression of SG31 epitope.
At least three independent mechanisms are utilized
to increase adhesive activities of the a4 integrins:
(i) increased levels of expression, (ii) clustering of a4
integrin receptors and (iii) conformational change and
activation by extracellular and intracellular signals
(Garratt and Humphries, 1995). Lymphoid cells
expressing high levels of the a4 integrins as detected
by PS/2 also express high levels of SG31 epitope, while
cells expressing moderate levels of the a4 integrins may
not express this epitope at all (Fig. 6). Our data
demonstrate that lymphocytes maximize their adhesive
FIGURE 8 SG31 selectively inhibits 38-b7 cell adhesion to ﬁbronectin.
The data are represented as mean and standard deviation from three
independent experiments. Statistical differences between adhesion in the
presence of control ab and SG31 or PS/2 were determined by Student’s
t test (**p , 0:001).
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active forms.
Different Usage of a4 Integrins on B and T Lymphoid
Lineages
Although B cells have a need to regulate their adhesion
activities during development, out data show that almost
all B lineage cells express a4 integrins and the SG31
epitope independent of their stage of development (Fig. 3).
In addition, the SG31 epitope on B cells is not further
up-regulated by Mn
2þ, suggesting that the a4 integrins on
B cells are constantly active and can be readily occupied
by ligands. Thus, other adhesion molecules on B lineage
cells or ligands of a4 integrins on stromal and endothelial
cells may be critical for controlling the migratory
behaviors of B cells.
In contrast, expression levels and activation states of
a4 integrins seem to play essential roles in thymocyte
development and activated T cell migration. The
expression of a4 integrins as detected by PS/2 is the
highest on the most immature DN thymocytes, and then
it is down-regulated with further thymocyte maturation.
The a4 integrins are expressed at low levels on mature
SP thymocytes (Fig. 4). The expression of the SG31
epitope does not always parallel that of the overall levels
of a4 integrins. DN thymocytes express the SG31
epitope at the same high levels as that of a4 integrins
(Fig. 4). SP thymocytes are almost negative for the
SG31 epitope though they still express low levels of a4
integrins. This pattern of expression suggests the
important roles of a4 integrins in thymocyte–stromal
interactions at early stages of development. In peripheral
lymphoid tissues, all T cells express the a4 integrins as
detected by PS/2, but only small subpopulations (both
CD4
þ and CD8
þ, data not shown) express the SG31
epitope (Fig. 2). Compared to SG31
2 T cells, SG31
þ T
cells express CD69, higher levels of CD44, CD11a and
CD54 (Fig. 5a and B). The SG31
þ population is also
enriched for CD62L
2, CD25
þ, and especially CD38
þ
cells in peripheral lymphoid tissues, such as mesenteric
lymph nodes. These results suggest that SG31
þ T cells
may be predominantly, activated T cells. Memory CD4
þ
T cells are CD11a
high, CD44
high and CD45RB
dull, and
are heterogeneous in terms of homing receptor
expression. They can be divided into aEb7
high,
a4b7
high (further subdivided into CD62L
þ and
CD62L
2) and a4b1
high subsets (Andrew et al., 1996).
Our data demonstrate that the activation epitope of a4
integrins as detected by SG31 can be a valuable addition
to these activation markers. St-Pierre et al. recently
demonstrated by adhesion assays that a4b1i s
constitutively expressed in its high-avidity state during
the early stages of T cell development (St-Pierre et al.,
1996). At later stages, mature thymocytes turn off a4b1
as well as aLb2 functions. Only antigen-challenged
peripheral mature T cells turn on the adhesion function
of a4b1 and aLb2. Our data ﬁt with these observations
and show that the expression of SG31 epitope
reﬂects the ﬂuctuation of a4b1 functions. Furthermore,
our data demonstrate the different roles of a4 integrins
in the development and function of B and T cell
lineages.
SG31 Provides a Unique Tool to Study a4 Integrins
Our results also conﬁrmed that the association of a4 and
b7 subunits on TK1 cells is dependent on the presence of
cations (Ruegg et al., 1992). a4
70 band was missing from
the SG31 precipitates in the absence of cations. This
observation suggests that b7 is important for maintaining
the structure of a4 subunits, especially the cleaved ones.
In other word, there is little interaction between a4
80 and
a4
70. In contrast to a4 subunits on TK1 cells, the a4
subunits in association with b1 on 38B9 cells do not
undergo signiﬁcant cleavage (Fig. 1c), supporting that
the cleavage of the integrin a4 subunits is cell-type
speciﬁc.
Due to lack of crystallographic structural analysis of a4
integrins, current knowledge of their structure–function
relationship is mainly derived from activity studies using
mAbs and truncated, chimeric and site-mutated a4
constructs. Cross-inhibition, inhibition of ligand binding
and induction or inhibition of homotypic cell aggregation
studies using a large panel of anti-human a4 Abs
identiﬁed three distinct and independent adhesion
activities (Pulido et al., 1991). Our preliminary studies
suggest that SG31 recognizes a region close to the
N-terminus of the a4 subunit. SG31 does not signiﬁcantly
induce TK1 cell aggregation, nor does it signiﬁcantly
inhibit TK1 cell aggregation induced by other mAbs.
Adhesion studies showed that SG31 inhibits a4b7-
expressing cell adhesion to ﬁbronectin, but not to
VCAM-1 or MAdCAM-1 (Fig. 8). Functional studies
showed that SG31 did not affect lymphopoiesis when
given in vivo. It did not affect thymocyte development in
fetal thymic organ culture or B cell development in long-
term bone marrow culture or bone marrow-stromal culture
(data not shown). However, mice treated with SG31 had a
dramatic reduction of CD62L
þ T cells in the peripheral
blood (data not shown), suggesting that SG31 interfered
with T cell trafﬁcking. In addition, our data showed that
most mesenteric lymph node T cells from mice with an
inﬂammatory bowel disease (scid transferal model)
express the SG31 epitope unlike their counterparts in
normal mice (manuscript in preparation), in agreement
with the previous ﬁndings that a4 integrins are involved in
the pathogenesis of this group of diseases. These ﬁndings
demonstrate that SG31 can be an important tool to
examine the activation status of a4 integrins in animals
with different diseases in which a4 integrins are involved,
to study the structural basis of molecular interactions
involved in the a4 integrins and their ligands, and to
explore the physiological and pathological functions of
such interactions.
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Animals
BALB/c and C3H/HeJ mice were purchased from Charles
River Laboratories, Inc. (Wilmington, MA) and bred in
the animal facility at the University of Alabama at
Birmingham.
Antibodies
Unless speciﬁed, antibodies were purchased from
PharMingen, San Diego, CA. The following antibodies
were used in this study: FITC-conjugated 145-2C11 (anti-
CD3e), 53-7.313 (anti-CD5), 53-6.7 (anti-CD8), 2D7
(anti-integrin aL subunit, CD11a), S7 (anti-CD43), 9C10
(anti-integrin a4 subunit, CD49d), H1.2F3 (anti-VEA,
CD69), polyclonal anti-mouse IgM, phycoerythrin (PE)-
conjugated IM7 (anti-CD44), Jo2 (anti-Fas, CD95), and
biotinylated-GK1.5 (anti-CD4), 7G6 (anti-CD21), 7D4
(anti-CD25), 90 (anti-CD38), 3E2 (anti-ICAM-1, CD54),
a n dM E L - 1 4( a n t i - L-selectin, CD62L). Cy-Chrome
(CY5)-conjugated 14.8 (anti-B220, CD45R) was pur-
chased from Southern Biotechnology Associates, Inc.
(Birmingham, AL). Hybridoma M293 (anti-integrin b7
subunit) was generously provided by PJ Kilshaw.
Hybridoma PS/2 (anti-integrin a4 subunit) and KMI6
(anti-integrin b1 subunit) were generously provided by
P.W. Kincade. An irrelevant rat g2a antibody (PharMin-
gen) was used as isotype-matched control. Second step
reagents were used as follows: FITC- or PE-conjugated
goat anti-rat IgG (GIBCO-BRL, Life Techno-
logies Corporate, Gaithersburg, MD) and Streptavidin
(SA)-CY5 (Southern Biotechnology Associates, Inc.,
Birmingham, AL). Antibodies from culture supernatants
were puriﬁed on protein G Sepharose (Pharmacia LKB,
Uppsala, Sweden) and quantiﬁed by measuring optical
density at 280nm.
Cell Lines
38B9 is a pro-B lymphoma expressing integrin subunits
a4 and b1. TK-1 is a spontaneous AKR/cum T cell
lymphoma expressing a4 and b7. 38-b7 cell line is a
38C13 pre-B lymphoma transfected with murine b7
cDNA. It expresses a4b7, but not a4b1
Generation of Hybridoma SG31
A subpopulation of Ab8
þ bone marrow cells (Moratz
et al., 1994) was FACS sorted and used to immunize a rat
subcutaneouly in multiple times at sites drained by the
popliteal and paraaortic lymph nodes. Cells from the
draining lymph nodes were then fused to the mouse
plasmacytoma cell line Ag8.653 resulting in the isolation
of Ab SG31 by screening against a variety of mouse
lymphoid tissues and cell lines. Puriﬁed SG31 were used
in this study and detected by PE- or FITC-conjugated goat
anti-rat IgG.
Flow Cytometry
Cells isolated from mouse lymphoid tissues or cell lines
were incubated with puriﬁed mAb (20mg/ml) in PBS
containing 2% FCS and 0.01% sodium azide for 20min on
ice, washed in PBS containing 2% FCS and incubated
with PE-conjugated goat anti-rat IgG for 20min on ice.
Flow cytometric analysis was performed on a FACScan or
a FACSCalibur (Becton Dickinson, Mountain View, CA).
The data were analyzed with WinList (Verity Software
House, Inc., Topsham, ME) or WinMDI (public domain
software, programmed by Joseph Trotter, obtained from
Scripps Research Institute) on personal computers. For
two- and three-parametric analysis, the cells were blocked
by incubation with 20ml of normal rat serum for 20min
on ice after the procedure described above to saturate the
binding sites on goat anti-rat IgG and then stained with
FITC-conjugated and biotinylated antibodies to other
surface markers. Biotinylated antibodies was detected by
SA-CY5.
To study the effects of a4 integrin activation on SG31
epitope expression, mouse lymphocytes were activated
with Ca
2þ,M g
2þ or Mn
2þ as described (Bargatze et al.,
1995; Berlin et al., 1995). Brieﬂy, splenic and mesenteric
lymph node cells were incubated at room temperature in
Ca
2þ/Mg
2þ-free Hanks balanced salt solution (HBSS)
plus 10mM HEPES (pH 7.2), pelleted, and resuspended in
HBSS/HEPES (control cells) or HBSS/HEPES containing
2mM CaCl2, MgCl2 or MnCl2. The cells were stained
accordingly and analyzed by ﬂow cytometry. The same
amount of cations were added in all reagents through the
staining procedure.
Immunoprecipitation
Radioiodination of TK-1 surface molecules was per-
formed by the lactoperoxidase method as described by
Laemmli (1970). The labeled cells were solubilized on ice
for 30min in lysis buffer (50mM Tris–HCl [pH 7.5],
150mM NaCl, 5mM EDTA, 20mM iodoacetamide, 0.1%
sodium azide, aprotonin [2mg/ml], 1mM PMSF, soybean
trypsin inhibitor [100mg/ml], leupeptin [1mg/ml], 20mM
e-amino-n-caproic acid, antipain [2mg/ml], chymostatin
[100mg/ml], pepstatin [1mg/ml], supplemented with 1%
NP-40. The lysis buffers were either supplemented with
cations by adding 5mM CaCl2, MgCl2 and MnCl2 each or
depleted of cations by adding 20mM EDTA and EGTA
each. The lysates were precleared by three incubations
each with BSA- and an irrelevant antibody-coupled Afﬁ-
gel 10 beads (Bio-Rad Laboratories, Hercules, CA) with
gentle rotation at 48C for 4h each time. SG31 reactive
membrane molecules were immunoprecipitated with
SG31-coupled Afﬁ-gel 10 beads, eluted with Laemmli
sample buffer, separated by SDS-PAGE (under either
F. SHU et al. 82reducing or non-reducing conditions), and detected by
autoradiography.
In other experiments, 38B9 lymphoma cells were
iodinated and lysed with 1% NP-40 lysis buffer.
Precleared lysates were further depleted with three rounds
of PS/2- or SG31-coupled Afﬁ-gel 10 beads and
precipitated with PS/2- and SG31-coupled Afﬁ-gel 10
beads. Lysates, which were not depleted in this way, were
precipitated with control antibody-, SG31- and PS/2-
coupled beads for comparison. Eluted materials were
subject to SDS-PAGE (7.5% acrylamide) under reducing
conditions, and detected by autoradiography.
Adhesion Assays
Adhesion assays were done as previously described by Hu
et al. (1992). Brieﬂy, Chinese hamster ovary cells (CHO)
transfected with MAdCAM-1 or VCAM-1 were allowed
to grow for 24h in 96-well plates to form conﬂuent
monolayers. Alternatively, plates were coated with
1mg/ml ﬁbronectin (Boehringer Mannheim, Germany)
in PBS for 16h at 48C. Subsequently, plates were washed
with cell adhesion buffer (24mM Tris–HCl [pH 7.4]
containing 137mM NaCl, 2.7mM KCl, 2mM glucose,
1mM CaCl 2, 1mM MgCl2, and 1% BSA). Lymphoma
cells were labeled for 30min at 378C with 12mg/ml
H33342 dye (Calbiochem, La Jolla, CA) in RPMI 1640
containing 1% BSA, washed twice with PBS, and
resuspended in cell adhesion buffer supplemented with
saturating amount (10mg/ml) of control Ab, PS/2, or
SG31. After incubation for 10min at room temperature,
80,000 cells were added to each well and centrifuged for
10min at 10g. Cells were allowed to adhere for 20min at
378C and non-adherent cells were removed by inverse
centrifugation for 10min at 50g. Adhesion assays were
quantiﬁed by ﬂuorimetry using a Cytoﬂuor 2300
(Millipore, Bedford, MA). The data were represented as
mean and standard deviation from three independent
experiments.
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